ArticlemedRxiv : the preprint server for health sciences2025
Spinal Cord Versus Brain Imaging Biomarkers of Multiple Sclerosis Trajectory Combining 7T and 3T MRI.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In multiple sclerosis (MS), 7 Tesla (7T) MRI improves the visualization of cortical (CLs) and white matter (WM) lesions with a paramagnetic rim (PRLs), associated with smoldering inflammation. Spinal cord (SC) atrophy is a critical determinant of clinical disability in MS, but its importance relative to PRLs and CLs in predicting neurological disability remains unclear. Purpose: To identify the most relevant predictors for baseline neurological disability and 4-year disease progression independent of relapse activity (PIRA) in a heterogeneous MS cohort. Materials and Methods: One-hundred-twelve MS patients (83 relapsing-remitting, 29 secondary progressive) were prospectively recruited between 2010 and 2024. 7T T2*-susceptibility-weighted imaging was acquired to segment CLs, PRLs, and non-rim WM lesions, and 3T T1-weighted brain MRI to estimate cortical thickness, brain WM volume, and the SC C2-C3 cross-sectional area (CSA) using FreeSurfer and Spinal Cord Toolbox. Expanded Disability Status Scale (EDSS) was assessed at baseline and longitudinally, in 97/112 MS patients, after a mean follow-up of 4.0 years. Associations between imaging metrics and clinical outcomes were evaluated using regression models. Results: Baseline EDSS was associated with non-rim WM lesion volume (p=<0.001), CL volume (p=0.001), brain WM volume (p=0.017), and C2-C3 CSA (p=0.003). At follow-up, 23/97 patients showed PIRA. PIRA was associated with PRL volume (p=0.030), CL volume (p=0.011), and brain WM volume (p<0.001). A stepwise logistic regression identified CL volume as the strongest independent predictor of PIRA (Nagelkerke R Conclusion: In MS, different imaging biomarkers are associated with either the current disability or PIRA. Spinal cord atrophy mainly explains the current EDSS, while brain WM atrophy and PRLs provide additional insights into future disability trajectory. Among all markers, CLs emerged as the main driver for PIRA.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.